Nasopharyngeal Carcinoma Latest Advances
Find the Latest Research About Nasopharyngeal Carcinoma
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25526 publications
Application of free tissue flaps using the facial artery and vein/retromandibular vein as recipient vessels in the repair of postoperative nasopharyngeal skull base necrosis
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: September 07, 2026
Research status of efficacy optimization strategies for precise radiotherapy combined with immunotherapy in nasopharyngeal carcinoma
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: September 07, 2026
Clinicopathologic characteristics and prognostic factors of mucoepidermoid carcinoma: a 20-year real-world cohort study.
Journal: ESMO real world data and digital oncology
Published: September 05, 2026
Ruscogenin Suppresses Nasopharyngeal Carcinoma Progression by Downregulating KDM1A to Co-induce Ferroptosis and Apoptosis.
Journal: Journal of visualized experiments : JoVE
Published: September 04, 2026
Internal validation of a novel risk classification system for juvenile nasopharyngeal angiofibroma involving the skull base: a comparative analysis of the Fisch-Andrews and UPMC staging systems
Journal: Vestnik otorinolaringologii
Published: September 04, 2026
Expert Consensus on Clinical Application of Izalontamab Brengitecan (2026 Edition)
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: August 30, 2026
Epstein-Barr Virus-Mediated Tumorigenesis in Nasopharyngeal Carcinoma.
Journal: Current topics in microbiology and immunology
Published: August 26, 2026
Integrative microbiome and functional profiling identify Streptococcus anginosus as a pro-tumorigenic driver in nasopharyngeal carcinoma.
Journal: mSystems
Published: August 25, 2026
Becotatug Vedotin Combined With Pucotenlimab in Platinum- and Immunotherapy-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 25, 2026
Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma.
Journal: NEJM evidence
Published: August 25, 2026
Optimizing Induction Therapy for High-Risk Nasopharyngeal Carcinoma.
Journal: NEJM evidence
Published: August 25, 2026
An evaluation of becotatug vedotin for the treatment of recurrent or metastatic nasopharyngeal cancer.
Journal: Expert opinion on biological therapy
Published: August 24, 2026
Last Updated: 09/26/2026